|
|
|
01.04.26 - 20:31
|
SpaceX Has Filed Confidentially For IPO, The AI Divide In Venture Capital | Bloomberg Deals 4/1/2026 (Bloomberg)
|
|
|
A weekly, midday program that delivers high-impact, editorially driven coverage of the most important corporate transactions shaping the global market. Today's guests: Bain Capital Managing Partner David Gross, Axiom Partners Founder Sandhya Venkatachalam, Salesforce Ventures Managing Partner Paul Drews, Westbridge Capital Principal and Head of US Investments Manthan Shah, and Morgan Stanley Global Co-Head of M&A Tom Miles. (Source: Bloomberg)...
|
|
|
|
|
|
|
01.04.26 - 18:12
|
′Excited & Daunted′ by AI Opportunities: Bain′s Gross (Bloomberg)
|
|
|
Bain Capital managing partner David Gross says his team sees AI opportunities "like a kid in a candy shop." He discusses his approach to AI investing, labor trends, and credit funds facing redemptions with Dani Burger on "Bloomberg Deals." (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19.03.26 - 16:06
|
Cape Raises $100M Series C to Power Private and Secure Mobile Connectivity for Enterprises, Government, and Consumers (Business Wire)
|
|
|
Backed by new investors, Cape is building deep infrastructure to rival traditional telecommunications carriers across multiple sectorsARLINGTON, Va.--(BUSINESS WIRE)--Cape, America's leading privacy-first mobile carrier, today announced it has raised a $100M Series C co-led by Bain Capital Ventures and IVP, with participation from new investors, 01 Advisors, 137 Ventures, Definition, and Fifth Down Capital. Cape has built a carrier from the ground up to protect U.S. government agencies, businesses, and privacy-conscious individuals against cellular security threats.
“Cell phone networks track everywhere you go, every app you use, every person you call or text,” said John Doyle, CEO of Cape. “So when they're compromised, it leads to some of the most sweeping and damaging violations of both national security and individual privacy in history. There's no app, no add-on that fixes problems inherent in the underlying cellular network itself, so we've redesigned a telco from scratch to close this gap....
|
|
|
|
|
|
|
|
|
|
|
18.03.26 - 13:09
|
Duravent Group, Venting and Air Quality Solutions Leader, Secures Strategic Growth Investment from Bain Capital (Business Wire)
|
|
|
Investment to accelerate Company's growth and further scale its industry-leading platformDETROIT--(BUSINESS WIRE)--Duravent Group™ (“Duravent” or the “Company”), a leader in the venting and air movement industries and trusted partner to HVAC professionals, today announced it has secured a significant strategic growth investment from Bain Capital. Bain Capital will partner with Duravent's leadership team, led by President and CEO Simon A. Davis, and Egeria, the Company's existing investor, to accelerate the Company's next phase of growth, deepen its category leadership, and expand its platform through both organic investments and strategic acquisitions. Financial terms of the private investment were not disclosed.
Headquartered in Detroit, Michigan, Duravent traces its heritage back to 1901 and has been a pioneering leader in venting solutions for over six decades. The Company operates 14 distinct brands in several locations across the United States, Canada, and Mexico. With world-class manuf...
|
|
|
|
|
17.03.26 - 21:21
|
Imperative Care Announces $100 Million Financing (Business Wire)
|
|
|
Funding supports continued growth and innovation in thromboembolic disease careCAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc., a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the closing of an oversubscribed $100 million convertible note financing.
The round was co-led by new investors Elevage Medical Technologies and Perceptive Advisors in partnership with existing investor Catalio Capital Management, LP. New investors Longaeva Partners LP and Brown Advisory also participated in the financing. The round was supported by Imperative Care's existing investors, including Ally Bridge Group and Bain Capital Life Sciences.
Imperative Care also announced the appointment of Evan Melrose, M.D., CEO of Elevage Medical Technologies, to its Board of Directors. A seasoned medtech investor and health care innovator, Dr. Melrose brings extensive experience built over decades identifying and supporting category‑defining medical ...
|
|
|
|